Kate qualified in Physiology (Kings College London) and Medicine (University of Leeds) in 2012. She moved to an Academic Clinical Fellowship (ACF) in the National Renal Complement Therapeutics Centre in Newcastle in 2015. During her ACF she has developed a transgenic mouse model of atypical haemolytic uraemic syndrome. This gain of function C3 mouse completely recapitulates the disease and she is using this model to test novel treatment strategies. Her work was recognised at the International Complement Society being awarded a travel grant and at the Complement UK conference where she received the Best Abstract and Presentation award.
Research Interest: To improve our understanding of complement mediated renal diseases and provide targeted therapy for patients.